Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia

Eur J Haematol. 2004 Jun;72(6):455-6. doi: 10.1111/j.1600-0609.2004.00237.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Catheterization, Central Venous / adverse effects
  • Critical Illness
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Female
  • Femoral Artery / injuries
  • Hemorrhage / drug therapy*
  • Hemorrhage / etiology
  • Humans
  • Leukemia, Promyelocytic, Acute / complications*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Recombinant Proteins / therapeutic use*
  • Transfusion Reaction
  • Tretinoin / adverse effects
  • Tretinoin / therapeutic use

Substances

  • Recombinant Proteins
  • Tretinoin
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa